COVAX

BIOLOGICAL2 trials

Sponsors

China National Biotec Group Company Limited

Conditions

COVID-19 Pneumonia

Phase 4

Evaluation of Immunogenicity and Safety of COVID-19 Vaccine (Produced in Wuhan) in Patients With Hypertension and/or Diabetes

China National Biotec Group Company LimitedCOVID-19 Pneumonia

Start: 2021-10-31End: 2022-03-31Target: 1440Updated: 2021-10-25

Evaluation of Immunogenicity and Safety of COVID-19 Vaccine (Produced in Beijing) in Patients With Hypertension and/or Diabetes

CompletedNCT05065879

China National Biotec Group Company LimitedCOVID-19 Pneumonia

Start: 2021-10-05End: 2022-01-05Updated: 2022-01-10

Related Papers

Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) in Hypertensive and/or Diabetic People Aged over 60 Years: A Prospective Open-Label Study.

2022-11-273 citations